Raymond Chang

Overview

Raymond Chang is a seasoned investor specializing in healthcare and technology sectors, with a focus on early and growth-stage companies in the United States and Asia. He has a strong background in medical devices, biotechnology, and pharmaceuticals, and has been involved in various successful ventures in these industries. His investment approach emphasizes innovation and scalability, aiming to support companies that have the potential to make a significant impact in the healthcare sector. In addition to his investment activities, Raymond Chang has held leadership roles in several healthcare organizations. He served as the CEO and member of the board of directors of Axonics, Inc., a global medical technology company that he co-founded in 2013 and took public in 2018. Under his leadership, Axonics achieved significant growth and was recognized as the fastest-growing company in the Americas in 2022. In November 2024, Axonics was acquired by Boston Scientific Corporation in a $3.7 billion transaction. Prior to Axonics, he was the CEO of Vessix Vascular, Inc., which was acquired by Boston Scientific in 2012. Raymond Chang's investment philosophy centers on identifying and nurturing companies that are at the forefront of medical innovation. He seeks to partner with entrepreneurs who are developing groundbreaking solutions to address unmet medical needs. His strategic vision and hands-on approach have contributed to the success of numerous healthcare ventures, making him a respected figure in the investment community.